June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Predictive Relationship of OCT Characteristics for Efficacy in an Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells (hRPC) for the Treatment of Retinitis Pigmentosa
Author Affiliations & Notes
  • Sunil Srivastava
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Peter K Kaiser
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Rebecca Kammer
    University of California Irvine, Irvine, California, United States
  • David S Boyer
    Retina Vitreous Associates, Los Angeles, California, United States
  • Jeffrey Heier
    OCB, Boston, Massachusetts, United States
  • Baruch D Kuppermann
    University of California Irvine, Irvine, California, United States
  • David Liao
    Retina Vitreous Associates, Los Angeles, California, United States
  • Mitul C Mehta
    University of California Irvine, Irvine, California, United States
  • Anthony Joseph
    OCB, Boston, Massachusetts, United States
  • Jing Yang
    University of California Irvine, Irvine, California, United States
  • Henry Klassen
    University of California Irvine, Irvine, California, United States
  • Footnotes
    Commercial Relationships   Sunil Srivastava, Abbvie (C), Allergan (F), Bausch (F), Eyepoint (F), Novartis (C), Regeneron (C), Santen (F); Peter Kaiser, J Cyte (F), J Cyte (C); Rebecca Kammer, J Cyte (C); David Boyer, J Cyte (F), J Cyte (C); Jeffrey Heier, J Cyte (F), J Cyte (C); Baruch Kuppermann, J Cyte (F), J Cyte (C); David Liao, J Cyte (F); Mitul Mehta, J Cyte (F); Anthony Joseph, J Cyte (F); Jing Yang, J Cyte (F), J Cyte (I), J Cyte (C), J Cyte (P), J Cyte (S); Henry Klassen, J Cyte (F), J Cyte (I), J Cyte (S), J Cyte (P)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3233. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sunil Srivastava, Peter K Kaiser, Rebecca Kammer, David S Boyer, Jeffrey Heier, Baruch D Kuppermann, David Liao, Mitul C Mehta, Anthony Joseph, Jing Yang, Henry Klassen; Predictive Relationship of OCT Characteristics for Efficacy in an Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells (hRPC) for the Treatment of Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3233.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The recession of the ellipsoid zone (EZ) and more generally the thinning of the outer zone have become potential structural surrogates for disease severity in retinitis pigmentosa (RP). During a Phase 2b trial conducted to evaluate the intravitreal injection of allogeneic hRPC for treatment of RP, spectral-domain optical coherence tomography (SD-OCT) baseline characteristics of subjects were explored to identify predictors of efficacy in a more responsive target population.

Methods : In a post hoc analysis, a target subgroup of patients with less measurement variability was identified (n=37). From this subgroup, readable SD-OCT volumetric data (n=29; sham, n=10, low dose, n=9, high dose, n=10) was analyzed. Frame by frame macular cube scans were processed using automated segmentation followed by EZ mapping with manual correction for segmentation errors by masked graders. A three-dimensional volume map of the EZ-RPE for the entire macular cube generated measures of mean foveal thickness within the subfield or mid-subfield, mean central foveal thickness (CFT), EZ-RPE subfield or mid-subfield volume and thickness (with or without fluid). Correlational analysis was performed between each OCT parameter and change in each of the phase 2b trial endpoints from baseline to 12 months (Best Corrected Visual Acuity, Contrast Sensitivity, Kinetic Visual Fields, Low Luminance Mobility Test, and a VFQ).

Results : Two parameters from the OCT analysis demonstrated moderate to strong correlations in all trial endpoints in the high dose (single injection of 6 x 106 cells) target group with most relationships being statistically significant despite the small sample size. The parameters were mean CFT (p<0.05 for BCVA, VF, CS, LLMT, VFQ) and mid-subfield mean EZ thickness (p<0.05 for VF, CS, VFQ) with greater values in each parameter corresponding to greater improvement in endpoints. The low dose (3 x 106 cells) did not demonstrate a significant relationship.

Conclusions : Given the small number of subjects in the target population subset and the post hoc nature of the analyses, these results should be viewed cautiously. However, we believe that having a certain minimum EZ or mean CFT thickness will facilitate selection of a population with the greatest chance for response in a phase 3 study from the neutrophic effects of hRPCs

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×